GMGlobus Medical GMED · NYSE
$76.69 -2.73% (-$2.15)
- Market cap
- $10.6B
- Enterprise value
- $10.2B
- P/E
- 19.8x
- Forward P/E
- 15.4x
- PEG
- 0.0x
- P/S
- 3.4x
- P/FCF
- 14.1x
- EV/EBITDA
- 11.6x
- ROIC
- 10.5%
- Gross margin
- 68.5%
- Net margin
- 17.0%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -0.5x
- Beta
- 0.96
- Free float
- 99.3%
About the company
Globus Medical, Inc. (GMED) is an American company specializing in the development, manufacturing, and distribution of orthopedic implants and surgical devices. With a wide portfolio of innovative products, Globus Medical is known for its efforts to improve treatment options for patients with spine conditions and injuries. The company focuses on providing high-quality and reliable products that help surgeons achieve optimal outcomes in surgical procedures. Globus Medical also invests in research and development of new technologies and products that enhance the lives of patients with musculoskeletal disorders. Globus Medical, Inc. (GMED) shares could be suitable for investors looking to invest in the healthcare sector with an emphasis on orthopedic implants and surgical devices.
Sector
Healthcare
Industry
Medical - Devices
CEO
Keith W. Pfeil
Employees
6,000
Headquarters
Audubon
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number